Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Approval for 0.5 mg capsules therapeutically equivalent to Novartis’ Gilenya; m...
Deal combines portfolios and expands presence across women’s health, biosimilar...
Among its provisions, the order directs the FDA to provide Commissioner’s Nation...
Key Takeaways The careful selection of a knee replacement implant is fundamental...
It’s the Monday of Match Week. You’ve checked your email, your heart is pounding...
Kev Patel explores the link between oral and cardiovascular health, from the lat...
Officials at One Biosciences say the company will bring its technology to the Al...
A cellular-resolution map of prenatal brain development in Down syndrome has bee...
Researchers created a novel microfluidic platform, AI tool, and risk score that ...
Orthopedic & Sports Medicine Specialists (OSMS) opened its new 28,000-square-foo...
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and ...
In this episode of GEN's Touching Base, editors discuss a variety of cancer news...
Inova reached a construction milestone for its Eastern Region expansion with “to...
I don’t need to tell you that AI is everywhere. Or that it is being used, increa...
The bottleneck isn’t discovery anymore. It’s execution. In peptides, programs ar...
The QS World University Rankings by subject has been released for 2026 – find ou...
